Valuation Beijing SL Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 28/10/2026			5-day change	1st Jan Change
5.090 ^CNY	+0.39%		-3.05%	-30.94%

09:56pm	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
25/08	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	10,376	11,106	8,445	10,469	7,674	7,572
Change	-	7.03%	-23.96%	23.97%	-26.69%	-1.34%
Enterprise Value (EV) ¹	8,939	9,472	6,992	8,390	5,692	6,430
Change	-	5.96%	-26.19%	20.01%	-32.16%	12.97%
P/E	28.1x	26.4x	35.7x	24.9x	-107x	-21.7x
PBR	2.09x	2.09x	1.54x	1.8x	1.38x	1.46x
PEG	-	1.9x	-0.8x	0.3x	1x	-0x
Capitalization / Revenue	9.32x	9.14x	8.04x	10.3x	11.6x	12.1x
EV / Revenue	8.03x	7.8x	6.66x	8.24x	8.62x	10.3x
EV / EBITDA	37.3x	30.3x	27.2x	23.5x	31.5x	40.4x
EV / EBIT	59.6x	44.6x	48.7x	39.7x	206x	-838x
EV / FCF	94.3x	83x	57.6x	66.4x	-21.9x	-176x
FCF Yield	1.06%	1.2%	1.74%	1.51%	-4.57%	-0.57%
Dividend per Share ²	0.1	0.1	0.1	0.15	0.02	0.01
Rate of return	0.99%	0.93%	1.22%	1.47%	0.27%	0.14%
EPS ²	0.36	0.41	0.23	0.41	-0.07	-0.34
Distribution rate	27.8%	24.4%	43.5%	36.6%	-28.6%	-2.94%
Net sales ¹	1,113	1,215	1,050	1,018	660.4	623.6
EBITDA ¹	239.4	312.1	257.2	356.5	180.6	159.1
EBIT ¹	149.9	212.5	143.7	211.1	27.65	-7.676
Net income ¹	364.7	425.9	234.4	416.7	-74.07	-347.2
Net Debt ¹	-1,437	-1,634	-1,453	-2,078	-1,982	-1,141
Reference price ²	10.100	10.810	8.220	10.190	7.470	7.370
Nbr of stocks (in thousands)	10,27,350	10,27,350	10,27,350	10,27,350	10,27,350	10,27,350
Announcement Date	26/04/21	25/04/22	25/04/23	23/04/24	21/04/25	28/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BEIJING SL PHARMACEUTICAL CO., LTD.	-	-	-	-	78Cr
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,14300Cr
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	65TCr
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	51TCr
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	38TCr
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	35TCr
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	29TCr
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	26TCr
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	24TCr
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	20TCr
Average	29.58x	7.09x	18.77x	2.12%	40.28TCr
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%